Skip Navigation


Glycobiology Advance Access originally published online on September 11, 2009
Glycobiology 2010 20(1):33-40; doi:10.1093/glycob/cwp139
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
20/1/33    most recent
cwp139v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Asplund, A.
Right arrow Articles by Bondjers, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asplund, A.
Right arrow Articles by Bondjers, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Hypoxic regulation of secreted proteoglycans in macrophages

Annika Asplund2, Pia Stillemark-Billton2, Erik Larsson2, Ellen Knutsen Rydberg2, Jonatan Moses2, Lillemor Mattsson Hultén2, Björn Fagerberg2, Germán Camejo2,3 and Göran Bondjers1,2,4

2 Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy, Göteborg University, Göteborg
3 AstraZeneca R & D, Mölndal
4 Nordic School of Public Health, Göteborg, Sweden

1 To whom correspondence should be addressed: Tel: +46 (0)31 693920; Fax: +46 (0)31 691777; e-mail: bondjers{at}nhv.se

Received on January 21, 2009; revised on September 1, 2009; accepted on September 2, 2009

Macrophages are prominent in hypoxic areas of atherosclerotic lesions, and their secreted proteoglycans (PG), such as versican, can modulate the retention of lipoproteins and the activity of enzymes, cytokines, and growth factors involved in atherogenesis. In this study, we report the effects of hypoxia on PG secreted by human monocyte-derived macrophages (HMDM) and the potential regulation by the transcription factor hypoxia-inducible factor (HIF-1{alpha} and HIF-2{alpha}). We found that versican co-localized with HIF-1{alpha} in macrophage-rich areas in human advanced atherosclerotic lesions. Versican and perlecan mRNA expression increased after exposure to 0.5% O2 (hypoxia) compared with 21% O2 (control cells). Using precursors to GAG biosynthesis combined with immunoabsorption with a versican antibody an increased versican synthesis was detected at hypoxia. Furthermore, siRNA knockdown of HIF-1{alpha} and HIF-2{alpha} in THP-1 cells showed that the hypoxic induction of versican and perlecan mRNA expression involved HIF signaling. Versican expression was co-regulated by HIF-1{alpha} and HIF-2{alpha} but expression of perlecan was influenced only by HIF-1{alpha} and not by HIF-2{alpha} knockdown. The results show that oxygen concentration is an important modulator of PG expression in macrophages. This may be a novel component of the complex role of macrophages in atherosclerosis.

Key words: HIF / hypoxia / macrophages / perlecan / versican


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.